219 related articles for article (PubMed ID: 22097200)
1. [Clinical effects of qianggan capsule on the liver tissue pathology and PDGF-BB, TGF-beta1, TIMP-1, and MMP-1 factors in patients with chronic hepatitis B].
Wang H; Yang LM; Huang L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1337-40. PubMed ID: 22097200
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
[TBL] [Abstract][Full Text] [Related]
3. [The diagnostic value of eight serum indices for liver fibrosis].
Cai WM; Zhang BB; Weng HL; Hu ZR; Lv J; Zheng M; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):219-22. PubMed ID: 15099471
[TBL] [Abstract][Full Text] [Related]
4. Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B.
Flisiak R; Al-Kadasi H; Jaroszewicz J; Prokopowicz D; Flisiak I
World J Gastroenterol; 2004 Sep; 10(18):2661-5. PubMed ID: 15309715
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Fuzheng Huayu Capsule on the ratio of TGF-beta1/BMP-7 of chronic viral hepatitis B fibrosis patients of Gan-Shen insufficiency blood-stasis obstruction syndrome].
Tang CL; Zhou Z; Shi WQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):20-4. PubMed ID: 22500384
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological study on effects of Qianggan Capsule combined lamivudine on hepatic fibrosis in patients with chronic hepatitis B].
Wang H; Zhao YL; Xu KC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Nov; 26(11):978-80. PubMed ID: 17186724
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
8. [The study of therapeutic effects of curcumin on hepatic fibrosis and variation of correlated cytokine].
Shu JC; Wang HL; Ye GR; He YJ; Lu X; Fang L
Zhong Yao Cai; 2007 Nov; 30(11):1421-5. PubMed ID: 18323214
[TBL] [Abstract][Full Text] [Related]
9. [Investigation on indication of fuzheng huayu capsule against hepatic fibrosis and its non-invasive efficacy evaluation parameters: data analysis of liver biopsy of 50 patients with chronic hepatitis B before and after treatment].
Hu YY; Liu P; Liu C
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):18-22. PubMed ID: 16466166
[TBL] [Abstract][Full Text] [Related]
10. Association between serum platelet-derived growth factor BB and degree of liver damage, fibrosis and hepatitis B e antigen (HBeAg) status in CHB patients.
Diang XC; Ma LN; Li YF; Liu XY; Zhang X; Liu JY; Sheng YJ; Zhang DZ; Hu HD; Ren H
Hepatogastroenterology; 2012; 59(120):2357-60. PubMed ID: 22688015
[TBL] [Abstract][Full Text] [Related]
11. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
[TBL] [Abstract][Full Text] [Related]
12. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
[TBL] [Abstract][Full Text] [Related]
13. [Influence of Feixian Formula on serum transforming growth factor-beta1 and platelet-derived growth factor in rats with bleomycin-induced pulmonary fibrosis].
Zhang W; Jiang LD; Zhang XM; Wu JJ; Deng Y; Lu XF
Zhong Xi Yi Jie He Xue Bao; 2008 Jun; 6(6):595-9. PubMed ID: 18559237
[TBL] [Abstract][Full Text] [Related]
14. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
[TBL] [Abstract][Full Text] [Related]
15. [Intervention of chronic hepatitis B liver fibrosis patients in different stages by syndrome typing and different activating blood removing stasis methods: a clinical study].
Liu SY; Zhang YQ; Liu YL; Guo P; Zhou CM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov; 33(11):1457-61. PubMed ID: 24483103
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic effect of Anluohuaxian capsule combined with adefovir dipivoxil on patients with chronic hepatitis B and influence on hepatic histology].
Jiang YF; Ma J; He B; Li NP; Tang W; Gong GZ
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):344-7. PubMed ID: 22971278
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between TGFbeta1 and TIMP-1 and its effects on the diagnosis of hepatic fibrosis].
Zhang LF; Tian XX; Wang CF
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):258-60. PubMed ID: 17456311
[TBL] [Abstract][Full Text] [Related]
19. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B.
Zhou J; Deng Y; Yan L; Zhao H; Wang G;
Int J Infect Dis; 2016 Aug; 49():94-9. PubMed ID: 27292607
[TBL] [Abstract][Full Text] [Related]
20. [A clinical study on combined serum hepatic fibrosis-related markers and ultrasound parameters to diagnose hepatic fibrosis].
Yu J; Jia CH; Wang Q; Xu PS; Zhang H; Zhao YQ; Shen Q; Hao YR; Cai GF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):56-8. PubMed ID: 17429537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
